LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study
LiveSMART
LiveSMART: A Sequential, Multiple Assignment Randomized Trial to Prevent Falls in Patients With Cirrhosis - Observational Study
2 other identifiers
observational
52
1 country
3
Brief Summary
The LIVE-SMART supplementary study will assess social determinants of health (income, education, neighborhood deprivation), financial burden (out-of-pocket costs, productivity loss), financial distress (patient and caregiver-reported outcomes), and financial toxicity (healthcare utilization) among LIVE-SMART participants and their caregivers. Participants for this supplementary study are participants in the primary study (NCT05794555) and their caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2023
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2023
CompletedFirst Submitted
Initial submission to the registry
August 18, 2025
CompletedFirst Posted
Study publicly available on registry
August 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedApril 29, 2026
February 1, 2026
2.8 years
August 18, 2025
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comprehensive Score for Financial Toxicity - Functional Assessment of Chronic Illness Therapy v2 (COST-FACIT)
Financial toxicity will be measured using the COST-FACIT v2 tool, a 12-item, validated self-reported scale validated reflecting experiences of the prior 7-days scored 0-44 (with higher scores indicating more toxicity).
Up to 72 weeks
Secondary Outcomes (3)
Medications
Up to 72 weeks
Work Productivity and Activity Impairment Questionnaire v2 (WPAI)
Up to 72 weeks
Out-of-pocket Healthcare Cost Questionnaire (OOP)
Up to 72 weeks
Study Arms (1)
Caregivers
Caregivers are a relative, spouse, partner, friend or neighbor who has a significant personal relationship with and provides a broad range of assistance for a patient, including consistent involvement in their medical care.
Eligibility Criteria
Caregivers are a relative, spouse, partner, friend or neighbor who has a significant personal relationship with and provides a broad range of assistance for a patient, including consistent involvement in their medical care.
You may qualify if:
- Adult 18 years of age or older
- Informal caregiver of a participant enrolled in LIVE-SMART
- English speaking
You may not qualify if:
- Non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University of Michigan
Ann Arbor, Michigan, 48109, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Baylor Scott & White Research Institute (BSW)
Dallas, Texas, 75246, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elliott Tapper, MD
University of Michigan
- PRINCIPAL INVESTIGATOR
Marina Serper, MD, MS
University of Michigan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Internal Medicine
Study Record Dates
First Submitted
August 18, 2025
First Posted
August 24, 2025
Study Start
June 13, 2023
Primary Completion
March 27, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
April 29, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share